title: Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysis.
authors.affiliation: Hematology department, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
authors.forename: Hampig Raphael
authors.initials: HR
authors.lastname: Kourie
authors.affiliation: Data centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
authors.forename: Lieveke
authors.initials: L
authors.lastname: Ameye
authors.affiliation: Data centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
authors.forename: Marianne
authors.initials: M
authors.lastname: Paesmans
authors.affiliation: Hematology department, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
authors.forename: Dominique
authors.initials: D
authors.lastname: Bron
mesh_terms: D037282:Calreticulin / Q000235:genetics*; D006801:Humans; D005810:Multigene Family; D009154:Mutation; D055728:Primary Myelofibrosis / Q000235:genetics* / Q000401:mortality*; D011379:Prognosis; D017594:Publication Bias; D018401:Sample Size; D015996:Survival Rate
chemical_list: D037282:Calreticulin
keywords: calreticulin 1; calreticulin 2; myeloproliferative neoplasm; primary myelofibrosis; survival